Reply to "Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?"

被引：2
|
作者：
Caminati, Marco [1 ,2 ]
Crisafulli, Ernesto [2 ,3 ,4 ]
Lunardi, Claudio [1 ,2 ]
Micheletto, Claudio [5 ]
Festi, Giuliana [5 ]
Maule, Matteo [6 ]
Giollo, Alessandro [2 ,7 ]
Orsolini, Giovanni [7 ]
Senna, Gianenrico [1 ,2 ,8 ,9 ]
机构：
[1] Univ Verona, Dept Med, Verona, Italy
[2] Verona Univ Hosp, Verona, Italy
[3] Univ Verona, Dept Med, Resp Med Unit, Verona, Italy
[4] Univ Verona, Dept Med, Sect Internal Med, Verona, Italy
[5] Integrated Univ Hosp, Resp Unit, Cardiothorac Dept, Verona, Italy
[6] Univ Verona, Specializat Course Allergy & Clin Immunol, Dept Med, Verona, Italy
[7] Univ Verona, Verona Univ Hosp, Dept Med, Div Rheumatol, Verona, Italy
[8] Verona Univ Hosp, Allergy Unit, Verona, Italy
[9] Verona Univ Hosp, Asthma Ctr, Verona, Italy
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE | 2021年 / 9卷 / 07期
关键词：
D O I：
10.1016/j.jaip.2021.04.029
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2943 / 2944
页数：2
相关论文
共 50 条
  • [41] Safety and effectiveness of mepolizumab therapy in remission induction therapy for eosinophilic granulomatosis with polyangiitis: a retrospective study
    Masanobu Ueno
    Ippei Miyagawa
    Takafumi Aritomi
    Koichi Kimura
    Shigeru Iwata
    Kentaro Hanami
    Syunsuke Fukuyo
    Satoshi Kubo
    Yusuke Miyazaki
    Shingo Nakayamada
    Yoshiya Tanaka
    Arthritis Research & Therapy, 24
  • [42] LOW-DOSE MEPOLIZUMAB EFFECTIVELY TREATS CHRONIC RELAPSING EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS
    Thompson, G.
    Vasilevski, N.
    Ryan, M.
    Baltic, S.
    Thompson, P.
    RESPIROLOGY, 2018, 23 : 178 - 178
  • [43] Justification of the Subcutaneous Mepolizumab Dose of 300 mg in Eosinophilic Granulomatosis With Polyangiitis and Hypereosinophilic Syndrome
    Pouliquen, Isabelle J.
    Austin, Daren
    Steinfeld, Jonathan
    Yancey, Steven W.
    CLINICAL THERAPEUTICS, 2021, 43 (07) : 1278 - 1280
  • [44] Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitis
    Steinfeld, Jonathan
    Bradford, Eric S.
    Brown, Judith
    Mallett, Stephen
    Yancey, Steven W.
    Akuthota, Praveen
    Cid, Maria C.
    Gleich, Gerald J.
    Jayne, David
    Khoury, Paneez
    Langford, Carol A.
    Merkel, Peter A.
    Moosig, Frank
    Specks, Ulrich
    Weller, Peter F.
    Wechsler, Michael E.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (06) : 2170 - 2177
  • [45] y Baseline Characteristics in Patients with Eosinophilic Granulomatosis with Polyangiitis in the US Initiating Mepolizumab
    Silver, Jared
    Deb, Arijita
    Packnett, Elizabeth
    McMorrow, Donna
    Morrow, Cynthia
    Bogart, Michael
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 231 - 232
  • [46] Clinical Features of Patients with Active Eosinophilic Granulomatosis with Polyangiitis Successfully Treated with Mepolizumab
    Tsurikisawa, Naomi
    Oshikata, Chiyako
    Watanabe, Maiko
    Fukuda, Nobuhiko
    Yamaguchi, Takanori
    Kiyohara, Hikari
    Kaneko, Takeshi
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2021, 182 (08) : 744 - 756
  • [47] Clinical Benefit of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis for Patients With and Without a Vasculitic Phenotype
    Terrier, Benjamin
    Jayne, David R. W.
    Hellmich, Bernhard H.
    Bentley, Jane
    Steinfeld, Jonathan W.
    Yancey, Steven
    Kwon, Namhee
    Akuthota, Praveen
    Khoury, Paneez
    Baylis, Lee E.
    Wechsler, Michael
    EGPA mepolizumab study team
    ACR OPEN RHEUMATOLOGY, 2023, 5 (07) : 354 - 363
  • [48] Efficacy and Safety of Mepolizumab During Maintenance Therapy in Patients with Eosinophilic Granulomatosis with Polyangiitis
    Sakai, Daiki
    Kaneko, Kaichi
    Furukawa, Karin
    Kawazoe, Mai
    Matsuzawa, Yasuo
    Nanki, Toshihiro
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1345 - 1347
  • [49] ORAL CORTICOSTEROID-SPARING EFFECT OF MEPOLIZUMAB IN PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS
    Wechsler, M.
    Jayne, D.
    Terrier, B.
    Hellmich, B.
    Bentley, J.
    Steinfeld, J.
    Yancey, S.
    Kwon, N.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : S7 - S7
  • [50] Pharmacogenetic investigation of efficacy response to mepolizumab in eosinophilic granulomatosis with polyangiitis
    Lynn D. Condreay
    Laura R. Parham
    Xiaoyan A. Qu
    Jonathan Steinfeld
    Michael E. Wechsler
    Benjamin A. Raby
    Steven W. Yancey
    Soumitra Ghosh
    Rheumatology International, 2020, 40 : 1301 - 1307
12345